Retatrutide (GLP-3)

Retatrutide is a triple-agonist research peptide currently studied for its combined action on GLP-1, GIP, and glucagon receptors. It is one of the most advanced compounds in metabolic and fat-loss research, designed to help scientists explore new pathways in energy balance, glucose regulation, and lipid metabolism. All Retatrutide sold by UK Peps is strictly for laboratory research use only, not for human use.

• Purity: >99% 
• Form: Lyophilised powder
• Storage: Store dry at -20°C; protect from light
• Solubility: Bacteriostatic water, sterile water, or suitable laboratory solvents
• Storage reconstituted: Store refrigerated (2-8°C)

Research focuses include:

• Triple hormone pathway modulation for enhanced energy expenditure and reduced appetite.

• Advanced obesity research, showing greater efficacy than dual-agonist treatments like Tirzepatide.

• Improvements in insulin action, lipid profile, and fatty liver models.

• Increased thermogenesis and metabolic rate, driven by glucagon receptor activity.

Retatrutide represents the next evolution in incretin-based research for weight loss and metabolic disease management.